Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis. Current concepts in management.

B Giesser

    Drugs
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Multiple sclerosis (MS) management focuses on symptom relief, as there is no cure. Treatments address spasticity, bladder dysfunction, and infection, with ongoing research into immune-modulating therapies to slow disease progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

    Neurology·2005
    Same author

    Multiple sclerosis gender issues: clinical practices of women neurologists.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2004
    Same author

    Field testing of a minimal record of disability in multiple sclerosis: the United States and Canada.

    Acta neurologica Scandinavica. Supplementum·1984
    Same author

    Multiple sclerosis bladder. Studies and care.

    Annals of the New York Academy of Sciences·1984
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    Same journal

    Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

    Drugs·2026
    Same journal

    Linerixibat: First Approval.

    Drugs·2026
    See all related articles

    Area of Science:

    • Neurology
    • Immunology
    • Urology

    Background:

    • Multiple sclerosis (MS) is a chronic, progressive central nervous system disease causing diverse dysfunctions.
    • While incurable, MS symptoms like spasticity and bladder issues can be managed to improve quality of life.

    Purpose of the Study:

    • To outline current management strategies for common symptoms in multiple sclerosis.
    • To discuss the role of various pharmacological and non-pharmacological interventions.
    • To highlight emerging therapeutic avenues for disease modification.

    Main Methods:

    • Review of established treatments for spasticity (e.g., baclofen).
    • Analysis of approaches to genitourinary dysfunction, including bladder management protocols.
    • Discussion of corticosteroid use in exacerbations and experimental immunomodulatory agents.

    Related Experiment Videos

    Main Results:

    • Baclofen is a primary treatment for spasticity.
    • Bladder dysfunction management involves anticholinergics and intermittent self-catheterization.
    • Corticosteroids aid acute exacerbation recovery but not long-term outcome; immune modulators are under investigation.

    Conclusions:

    • Symptomatic management is key in multiple sclerosis care.
    • Effective treatments exist for spasticity and bladder dysfunction.
    • Research into immunomodulatory therapies offers hope for slowing MS progression.